Endothelial nitric oxide synthase gene polymorphisms and prostate cancer risk in serbian population

International Journal of Experimental Pathology

Volumn 94, Issue 6, 2013, Pages 355-361

  Branković, Ana ^a   Brajušković, Goran ^a   Nikolić, Zorana ^a   Vukotić, Vinka ^b   Cerović, Snežana ^c   Savić Pavićević, Dušanka ^a   Romac, Stanka ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b Department of Urology   (Serbia)

^c UNIVERSITY OF DEFENCE   (Serbia)

Author keywords

Genetic variation; Nitric oxide synthase; Prostate cancer; Single nucleotide polymorphism

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ADULT; AGED; ALLELE; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER RISK; CONTROLLED STUDY; DNA SEQUENCE; GEL ELECTROPHORESIS; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SERBIA;

GENETIC VARIATION; NITRIC OXIDE SYNTHASE; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; CASE-CONTROL STUDIES; DISEASE PROGRESSION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROSTATIC NEOPLASMS; RISK FACTORS; SERBIA;

EID: 84887403926     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/iep.12045     Document Type: Article

References (46)

1. Cancer Registry of Central Serbia, Institute of Public Health of the Republic of Serbia 1999-2009. Available at: http://www.batut.org.rs/ (Accessed 2 March 2012).
2. Alonso V., Neves A.F., Marangoni K. et al. (2009) Gene expression profile in the peripheral blood of patients with prostate cancer and benign prostatic hyperplasia. Cancer Detect. Prev. 32, 336-337.
3. Catalona W.J., Hudson M.A., Scardino P.T. et al. (1994) Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves. J. Urol. 152, 2037-2042.
4. Center M.M., Jemal A., Lortet-Tieulent J. et al. (2012) International variation in prostate cancer incidence and mortality rates. Eur. Urol. 61, 1079-1092.
5. Cruz-González I., Corral E., Sánchez-Ledesma M., Sánchez-Rodríguez A., Martín-Luengo C., González-Sarmiento R. (2009) Association between -T786C NOS3 polymorphism and resistant hypertension: a prospective cohort study. BMC. Cardiovasc. Disord. 9, 35.
6. D'Amico A.V., Whittington R., Malkowicz S.B. et al. (1998) Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280, 969-974.
7. Dasgupta S., Srinidhi S., Vishwanatha J.K. (2012) Oncogenic activation in prostate cancer progression and metastasis: molecular insights and future challenges. J. Carcinog. 11, 4-17.
8. Forstermann U., Boissel J.P., Kleinert H. (1998) Expressional control of the 'constitutive' isoforms of nitric oxide synthase (NOS I and NOS III). FASEB. J. 12, 773-790.
9. Gimbrone M.A., Leapman S., Cotran R.S., Folkman J. (1972) Tumor dormancy in vivo by prevention of neovascularizaion. J. Exp. Med. 136, 261-276.
10. Gleason D.F. & Mellinger G.T. (1974) Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J. Urol. 111, 58-64.
11. Goh C.L., Schumacher F.R., Easton D. et al. (2012) Genetic variants associated with predisposition to prostate cancer and potential clinical implications. J. Intern. Med. 271, 353-365.
12. Grande M., Carlstrom K., Stege R., Pousette A., Faxen M. (2000) Estrogens increases the endothelial nitric oxide synthase (ecNOS) mRNA level in LNPCa human prostate carcinoma cells. Prostate 45, 232-237.
13. Hällström T.M. & Laiho M. (2008) Genetic changes and DNA damage responses in the prostate. Prostate 68, 902-918.
14. He Y., Fan Z., Zhang J. et al. (2011) Polymorphisms of eNOS gene are associated with diabetic nephropathy: a meta-analysis. Mutagenesis 26, 339-349.
15. Howard T.D., Giles W.H., Xu J. et al. (2005) Promoter polymorphisms in the nitric oxide synthase 3 gene are associated with ischemic stroke susceptibility in young black women. Stroke 36, 1848-1851.
16. Kim J.E. & Tannenbaum S.R. (2004) S-Nitrosation regulates the activation of endogenous procaspase-9 in HT-29 human colon carcinoma cells. J. Biol. Chem. 279, 9758-9764.
17. Konishi N., Shimada K., Ishida E., Nakamura M. (2005) Molecular pathology of prostate cancer. Pathol. Int. 55, 531-539.
18. Lala P.K. & Orucevic A. (1998) Role of nitric oxide in tumor progression: lessons from experimental tumors. Cancer Metast. Rev. 17, 91-106.
19. Lee K.M., Kang D., Park S.K. et al. (2009) Nitric oxide synthase gene polymorphisms and prostate cancer risk. Carcinogenesis 30, 621-625.
20. Marangoni K., Neves A.F., Cardoso A.M., Santos W.K., Faria P.C., Goulart L.R. (2006) The endothelial nitric oxide synthase Glu-298-Asp polymorphism and its mRNA expression in the peripheral blood of patients with prostate cancer and benign prostatic hyperplasia. Cancer Detect. Prev. 30, 7-13.
21. Marangoni K., Araújo T.G., Neves A.F., Goulart L.R. (2008) The -786T>C promoter polymorphism of the NOS3 gene is associated with prostate cancer progression. BMC Cancer. 8, 273.
22. Medeiros R.M., Morais A., Vasconcelos A. et al. (2002) Outcome in prostate cancer: association with endothelial nitric oxide synthase Glu-Asp298 polymorphism at exon 7. Clin. Cancer Res. 8, 3433-3437.
23. Miyamoto Y., Saito Y., Nakayama M. et al. (2000) Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a 786T→C mutation associated with coronary spastic angina. Hum. Mol. Genet. 9, 2629-2637.
24. Mocellin S., Bronte V., Nitti D. (2007) Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities. Med. Res. Rev. 27, 317-352.
25. -786T→C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99, 2864-2870.
26. Niu W. & Qi Y. (2011) An updated meta-analysis of endothelial nitric oxide synthase gene: three well-characterized polymorphisms with hypertension. PLoS ONE 6, e24266. Epub 2011 Sep 2.
27. Purcell S., Neale B., Todd-Brown K. et al. (2007) PLINK: a toolset for whole-genome association and population-based linkage analysis. Am. J. Hum. Genet. 81, 559-575.
28. Rosas-Vargas H., Coral-Vasquez R.M., Tapia R., Borja J.L., Salas R.A., Salamanca F. (2004) Glu298Asp endothelial nitric oxide synthase polymorphism is a risk factor for erectile dysfunction in the Mexican Mestizo population. J. Androl. 25, 728-732.
29. Safarinejad M.R., Shafiei N., Safarinejad S. (2010) The role of endothelial nitric oxide synthase (eNOS) T-786C, G894T, and 4a/b gene polymorphisms in the risk of idiopathic male infertility. Mol. Reprod. Dev. 77, 720-727.
30. Safarinejad M.R., Safarinejad S., Shafiei N., Safarinejad S. (2012) Effects of the T-786C, G894T, and intron 4 VNTR (4a/b) polymorphisms of the endothelial nitric oxide synthase gene on the risk of prostate cancer. Urol. Oncol. 31, 1132-1140.
31. Sakai T., Shikishima K., Matsushima M., Kitahara K. (2007) Endothelial nitric oxide synthase gene polymorphisms in non-arteritic anterior ischemic optic neuropathy. Graefes Arch. Clin. Exp. Ophthalmol. 245, 288-292.
32. Salvucci O., Carsana M., Bersani I., Tragni G., Anichini A. (2001) Antiapoptotic role of endogenous nitric oxide in human melanoma cells. Cancer Res. 61, 318-326.
33. Senthil D., Raveendran M., Shen Y.H. et al. (2005) Genotype-dependent expression of endothelial nitric oxide synthase (eNOS) and its regulatory proteins in cultured endothelial cells. DNA Cell Biol. 24, 218-224.
34. Sinici I., Güven E.O., Serefoglu E., Hayran M. (2010) T-786C polymorphism in promoter of eNOS gene as genetic risk factor in patients with erectile dysfunction in Turkish population. Urology 75, 955-960.
35. Taylor B.S., Schultz N., Hieronymus H. et al. (2010) Integrative genomic profiling of human prostate cancer. Cancer Cell 18, 11-22.
36. Tesauro M., Thompson W.C., Rogliani P., Qi L., Chaudhary P.P., Moss J. (2000) Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc. Natl Acad. Sci. USA 97, 2832-2835.
37. Torok N.J., Higuchi H., Bronk S., Gores G.J. (2002) Nitric oxide inhibits apoptosis downstream of cytochrome C release by nitrosylating caspase 9. Cancer Res. 62, 1648-1653.
38. Vrdoljak E., Wojtukiewicz M.Z., Pienkowski T. et al. (2011) Cancer epidemiology in Central and South Eastern European countries. Croat. Med. J. 52, 478-487.
39. Wallis Y. & Morrell N. (2011) Automated DNA sequencing. Methods Mol. Biol. 688, 173-185.
40. Wang X.L. & Wang J. (2000) Endothelial nitric oxide synthase gene sequence variations and vascular disease. Mol. Genet. Metab. 70, 241-251.
41. Wartenberg M., Schallenberg M., Hescheler J., Sauer H. (2003) Reactive oxygen species-mediated regulation of eNOS and iNOS expression in multicellular prostate tumor spheroids. Int. J. Cancer 104, 274-282.
42. Weidner N., Carroll P.R., Flax J., Blumenfeld W., Folkman J. (1993) Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am. J. Pathol. 143, 401-409.
43. Wilcox J.N., Subramanian R.R., Sundell C.L. et al. (1997) Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arterioscler. Thromb. Vasc. Biol. 17, 2479-2488.
44. Yoon Y., Song J., Hong S.H., Kim J.Q. (2000) Plasma nitric oxide concentrations and nitric oxide synthase gene polymorphisms in coronary artery disease. Clin. Chem. 46, 1626-1630.
45. Yoshimura T., Hisatomi A., Kajihara S. et al. (2003) The relationship between insulin resistance and polymorphisms of the endothelial nitric oxide synthase gene in patients with coronary artery disease. J. Atheroscler. Thromb. 10, 43-47.
46. Yu Y.P. & Luo J.H. (2007) Pathological factors evaluating prostate cancer. Histol. Histopathol. 22, 1291-1300.